Floatz logo

SIMVASTATIN

Alcohol Abuse

Anna CrucetaSmall moleculePhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Alcohol Abuse cohort.

Asset / SponsorPhaseRating
Cipralex
University of Texas Southwestern Medical Center
Phase 4BBB
Seroquel®
University of Cincinnati
Phase 4BBB
Naltrexone
VA Connecticut Healthcare System
Phase 4BBB
Topamax
University of California, San Francisco
Phase 4BB
Risperdal
Dartmouth-Hitchcock Medical Center
Phase 4BB

View all 28 →

Same molecule, other indications

SIMVASTATIN is also rated in:

HypercholesterolemiaDormant
BBB
Indicative ·
76 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
75 / 100
View asset →
inherited lipid metabolism disorderDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →